Treatment of dysplastic Barrett’s esophagus using a novel over-the-scope device for hybrid argon plasma coagulation

Key Points

• The aim is to assess the effectiveness of a novel device for treating dysplastic Barrett's esophagus with hybrid argon plasma coagulation.
• Utilized the ArgoCap system for the hybrid argon plasma coagulation procedure.
• Performed ablative treatment to achieve significant tissue response.
• Included imaging to evaluate treatment outcomes.
• Successful treatment demonstrated with significant ablation results post-procedure.
• Notable improvement in the condition of patients with dysplastic Barrett's esophagus.
• Promising data supports continued use of the ArgoCap system for this intervention.